Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression
- 1 November 2006
- journal article
- research article
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 31 (10) , 1154-1163
- https://doi.org/10.1016/j.psyneuen.2006.08.001
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Triiodothyronine Addition to Paroxetine in the Treatment of Major Depressive DisorderJournal of Clinical Endocrinology & Metabolism, 2004
- Hypothalamic-Pituitary-Adrenocortical System and Mood Disorders: Highlights from Mutant MiceNeuroendocrinology, 2004
- Lithium Augmentation Increases the ACTH and Cortisol Response in the Combined DEX/CRH Test in Unipolar Major Depression,Neuropsychopharmacology, 2002
- Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depressionJournal of Psychiatric Research, 2001
- A Glucocorticoid Receptor Gene Marker Is Associated with Abdominal Obesity, Leptin, and Dysregulation of the Hypothalamic‐Pituitary‐Adrenal AxisObesity Research, 2000
- Establishment of reference values for endocrine tests I. Cushing's syndromeThe Netherlands Journal of Medicine, 1998
- Thyroid-stimulating hormone responses after single administration of thyrotropin-releasing hormone and combined administration of four hypothalamic releasing hormones in beagle dogsDomestic Animal Endocrinology, 1996
- Antidepressants and Hypothalamic-Pituitary-Adrenocortical RegulationEndocrine Reviews, 1996
- The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disordersJournal of Psychiatric Research, 1994
- Increased Numbers of Corticotropin-Releasing Hormone Expressing Neurons in the Hypothalamic Paraventricular Nucleus of Depressed PatientsNeuroendocrinology, 1994